Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TERT | O14746 | 3/20 | 0.63 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.63 |
| ▸ | PPARG | P37231 | 3/20 | 0.63 |
| ▸ | PPARD | Q03181 | 3/20 | 0.63 |
| ▸ | PPARA | Q07869 | 3/20 | 0.63 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.63 |
| ▸ | MAPT | P10636 | 2/20 | 0.63 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.63 |
| ▸ | BLM | P54132 | 2/20 | 0.63 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.63 |
| ▸ | FABP4 | P15090 | 2/20 | 0.63 |
| ▸ | FAAH | O00519 | 2/20 | 0.63 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.63 |
| ▸ | F7 | P08709 | 2/20 | 0.63 |
| ▸ | F3 | P13726 | 2/20 | 0.63 |
| ▸ | GMNN | O75496 | 1/20 | 0.63 |
| ▸ | USP2 | O75604 | 1/20 | 0.63 |
| ▸ | LMNA | P02545 | 1/20 | 0.63 |
| ▸ | POLB | P06746 | 1/20 | 0.63 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.63 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29531051 | 1.00 | TERT (0.63) | TERTPTPN1PPARGPPARDPPARA | |
| SCHEMBL6673278 | 1.00 | TERT (0.63) | TERTPTPN1PPARGPPARDPPARA | |
| SCHEMBL2233674 | 1.00 | TERT (0.63) | TERTPTPN1PPARGPPARDPPARA | |
| SCHEMBL321848 | 1.00 | TERT (0.63) | TERTPTPN1PPARGPPARDPPARA | |
| SCHEMBL5570249 | 0.98 | TERT (0.61) | TERTPTPN1PPARGPPARDPPARA | |
| SCHEMBL5902724 | 0.98 | TERT (0.61) | TERTPTPN1PPARGPPARDPPARA | |
| SCHEMBL5570243 | 0.98 | TERT (0.61) | TERTPTPN1PPARGPPARDPPARA | |
| SCHEMBL28802018 | 0.98 | TERT (0.61) | TERTPTPN1PPARGPPARDPPARA | |
| SCHEMBL193741 | 0.95 | ALDH1A1 (0.67) | PPARGPPARDPPARAHSD17B10FABP4 | |
| SCHEMBL29049577 | 0.95 | TERT (0.58) | TERTPTPN1PPARGPPARDPPARA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 126 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250249106-A1 | Olfactory Delivery Scaffolds Using Peptides and Methods for Making and Using Same | OLFERA CORPORATION | 2025-08-07 | — | — | US | claimed |
| CN-118955253-A | Fatty alcohol polyether type nonionic surfactant, and preparation method and application thereof | 太原理工大学 | 2024-11-15 | — | — | CN | claimed |
| CN-116987245-B | Thermoplastic pipeline non-excavation repair material and preparation method thereof | 杰瑞高科(广东)有限公司 | 2024-02-02 | — | — | CN | claimed |
| CN-116987245-A | Thermoplastic pipeline non-excavation repair material and preparation method thereof | 杰瑞高科(广东)有限公司 | 2023-11-03 | — | — | CN | claimed |
| CN-106076653-B | A kind of preparation method of modified fat acid type Collophane anti-floatation collector | 武汉工程大学 | 2018-08-24 | — | — | CN | claimed |
| CN-104056724-B | Reverse flotation collector for hematite and preparation and use method thereof | 北京矿冶研究总院 | 2017-08-04 | — | — | CN | claimed |
| CN-106076653-A | A kind of preparation method of modified fat acid type Collophane anti-floatation collector | 武汉工程大学 | 2016-11-09 | — | — | CN | claimed |
| CN-103801462-B | A kind of oxide ore ore floatation collecting agent | XIAO GUOGUANG (CN) | 2016-05-25 | — | — | CN | claimed |
| CN-102746180-B | Preparation method for hydroxyethyl dual fatty acid amide | CHANGZHOU KESAI SUCCESS PLASTICAL MATERIALS CO LTD | 2014-12-03 | — | — | CN | claimed |
| CN-104056724-A | Reverse flotation collector for hematite and preparation and use method thereof | BEIJING GEN RES INST MINING | 2014-09-24 | — | — | CN | claimed |
| CN-102227211-A | Pharmaceutical formulation comprising diclofenac and hydroxy fatty acid polyoxyalkylene ester | ADVANCE HOLDINGS LTD | 2011-10-26 | — | — | CN | claimed |
| WO-2011103193-A2 | COPOLYESTERS HAVING REPEAT UNITS DERIVED FROM ω-HYDROXY FATTY ACIDS | SYNTHEZYME LLC (US) | 2011-08-25 | — | — | WO | claimed |
| CN-101613267-A | Dihydroxyoleic acid, preparation method and application thereof | ZHONGSHAN UNICARE NATURAL MEDI | 2009-12-30 | — | — | CN | claimed |
| CN-101473020-A | Lubricating oil composition | SHELL INT RESEARCH (NL) | 2009-07-01 | — | — | CN | claimed |
| CN-101177029-A | Method of preparing complex epoxy ester series lubricant agent special for polyvinyl chloride buckle | LI XIONGWEI LI JIANCHENG (CN) | 2008-05-14 | — | — | CN | claimed |
| CN-101173103-A | Method of producing polyvinyl ester chloride inside and outside lubricant agent | XIONGWEI LI (CN) | 2008-05-07 | — | — | CN | claimed |
| EP-1594481-A4 | MONOUNSATURATED FATTY ACIDS AND PERHYDROCYCLOPENTANOPHENANTHRENE NUCLEUS COMBINATION MOLECULES, AND THEIR PRECURSORS, AND THE USE OF ALL OF THESE AS WEIGHT-LOSS AGENTS | GIROUARD MICHAEL P (US) | 2006-05-17 | — | — | EP | claimed |
| EP-1594481-A2 | MONOUNSATURATED FATTY ACIDS AND PERHYDROCYCLOPENTANOPHENANTHRENE NUCLEUS COMBINATION MOLECULES, AND THEIR PRECURSORS, AND THE USE OF ALL OF THESE AS WEIGHT-LOSS AGENTS | Girouard, Michael P. (US) | 2005-11-16 | — | — | EP | claimed |
| US-20040157816-A1 | Monounsaturated fatty acids and perhydrocyclopentanophenanthrene nucleus combination molecules, and their precursors, and the use of all of these as weight-loss agents | GIROUARD MICHAEL P (US) | 2004-08-12 | — | — | US | claimed |
| WO-2004045560-A2 | COMBINATION OF MONOUNSATURATED FATTY ACIDS AND ESTOGEN, AND THEIR USE | GIROUARD MICHAEL P (US) | 2004-06-03 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250249106-A1 | Olfactory Delivery Scaffolds Using Peptides and Methods for Making and Using Same | OR51E2, OR10J3, GAP43 | TERT 4188/4885PTPN1 3452/4885PPARG 4065/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.